Title |
Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
|
---|---|
Published in |
Frontiers in oncology, June 2018
|
DOI | 10.3389/fonc.2018.00202 |
Pubmed ID | |
Authors |
Hildur Helgadottir, Iara Rocha Trocoli Drakensjö, Ada Girnita |
Abstract |
Despite enormous international efforts, skin melanoma is still a major clinical challenge. Melanoma takes a top place among the most common cancer types and it has one of the most rapidly increasing incidences in many countries around the world. Until recent years, there have been limited options for effective systemic treatment of disseminated melanoma. However, lately, we have experienced a rapid advancement in the understanding of the biology and molecular background of the disease. This has led to new molecular classifications and the development of more effective targeted therapies adapted to distinct melanoma subtypes. Not only are these treatments more effective but they can be rationally prescribed to the patients standing to benefit. As such, melanoma management has now become one of the most developed for personalized medicine. The aim of the present paper is to summarize the current knowledge on melanoma molecular classification, predictive markers, combination therapies, as well as emerging new treatments. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 87 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 15% |
Student > Master | 12 | 14% |
Researcher | 10 | 11% |
Student > Bachelor | 9 | 10% |
Other | 6 | 7% |
Other | 10 | 11% |
Unknown | 27 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 23 | 26% |
Medicine and Dentistry | 18 | 21% |
Agricultural and Biological Sciences | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Neuroscience | 2 | 2% |
Other | 5 | 6% |
Unknown | 30 | 34% |